- abnormal maxilla morphology / IMPC
- abnormal urinary bladder morphology / IMPC
- decreased body weight / IMPC
- decreased locomotor activity / IMPC
- decreased circulating chloride level / IMPC
- abnormal cholesterol homeostasis / IMPC
- impaired glucose tolerance / IMPC
- increased mean corpuscular hemoglobin / IMPC
- decreased circulating sodium level / IMPC
- increased aggression / IMPC
- increased fasting circulating glucose level / IMPC
- increased freezing behavior / IMPC
C57BL/6NCrl-Insig1em1(IMPC)Ccpcz/Ph
Status | Available to order |
EMMA ID | EM:11914 |
Citation information | RRID:IMSR_EM:11914 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NCrl-Insig1em1(IMPC)Ccpcz/Ph |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Insig1em1(IMPC)Ccpcz |
Gene/Transgene symbol | Insig1 |
Information from provider
Provider | Institute of Molecular Genetics |
Provider affiliation | Department of Transgenic Models of Diseases, Institute of Molecular Genetics |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Animals used for archiving | heterozygous C57BL/6NCrl males |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased mean corpuscular hemoglobin / IMPC
- decreased body weight / IMPC
- impaired glucose tolerance / IMPC
- increased aggression / IMPC
- decreased circulating chloride level / IMPC
- decreased circulating sodium level / IMPC
- abnormal cholesterol homeostasis / IMPC
- abnormal urinary bladder morphology / IMPC
- abnormal maxilla morphology / IMPC
- increased freezing behavior / IMPC
- decreased locomotor activity / IMPC
- increased fasting circulating glucose level / IMPC
MGI phenotypes (gene matching)
- decreased body length / MGI
- decreased body weight / MGI
- decreased circulating triglyceride level / MGI
- homeostasis/metabolism phenotype / MGI
- behavior/neurological phenotype / MGI
- abnormal white fat cell morphology / MGI
- increased gonadal fat pad weight / MGI
- increased subcutaneous adipose tissue amount / MGI
- abnormal white fat cell differentation / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).